Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Industry
Pharmaceutical Preparations
Location
455 Mission Bay Boulevard South, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
INHALE THERAPEUTIC SYSTEMS INC (to 1/10/2003), INHALE THERAPEUTIC SYSTEMS (to 5/14/1998)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 539 % -33.7%
Quick Ratio 20.5 % -37.2%
Debt-to-equity 274 % +112%
Return On Equity -174 % -43%
Return On Assets -46.6 % +12.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184M shares -3.31%
Common Stock, Shares, Outstanding 184M shares -3.31%
Entity Public Float 109M USD -84.5%
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 209M shares +9.9%
Weighted Average Number of Shares Outstanding, Diluted 209M shares +9.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 93.1M USD +5.53%
Research and Development Expense 122M USD +2.64%
General and Administrative Expense 76.9M USD -6.22%
Costs and Expenses 246M USD -33.6%
Operating Income (Loss) -153M USD +45.8%
Nonoperating Income (Expense) -15.3M USD -89.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -168M USD +42.1%
Income Tax Expense (Benefit) -9K USD -100%
Net Income (Loss) Attributable to Parent -168M USD +42.7%
Earnings Per Share, Basic -0.83 USD/shares +46.8%
Earnings Per Share, Diluted -0.83 USD/shares +46.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.1M USD -53.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Other Assets, Current 8.93M USD -1.11%
Assets, Current 286M USD -28.2%
Property, Plant and Equipment, Net 3.6M USD -81.9%
Operating Lease, Right-of-Use Asset 8.83M USD -52.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 4.52M USD -0.09%
Assets 308M USD -30.4%
Accounts Payable, Current 8.58M USD +161%
Employee-related Liabilities, Current 7.01M USD -38.9%
Accrued Liabilities, Current 32.4M USD +8.91%
Liabilities, Current 67.6M USD +29.7%
Operating Lease, Liability, Noncurrent 86.8M USD -15.1%
Other Liabilities, Noncurrent 6.91M USD +39.3%
Liabilities 259M USD -8.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax 355K USD
Retained Earnings (Accumulated Deficit) -3.6B USD -4.9%
Stockholders' Equity Attributable to Parent 48.9M USD -69.3%
Liabilities and Equity 308M USD -30.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.9M USD +7.76%
Net Cash Provided by (Used in) Financing Activities 42M USD
Net Cash Provided by (Used in) Investing Activities 19.3M USD -52.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 193M shares +1.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.1M USD -53.6%
Deferred Tax Assets, Valuation Allowance 855M USD +4.69%
Deferred Tax Assets, Gross 859M USD +3.7%
Operating Lease, Liability 118M USD -10.4%
Payments to Acquire Property, Plant, and Equipment 157K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -162M USD +44.6%
Lessee, Operating Lease, Liability, to be Paid 140M USD -13%
Operating Lease, Liability, Current 21.5M USD +12.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.3M USD +3.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.8M USD +3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.7M USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23M USD +3.16%
Deferred Tax Assets, Operating Loss Carryforwards 575M USD +5.36%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 126M USD +47.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.7M USD +3.15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 4.09M USD -65.3%
Share-based Payment Arrangement, Expense 24.1M USD -38.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%